Yesterday
Capsida Biotherapeutics emerges from stealth with $140m Longevity Technology18:45 7-Nov-25
In the last 7 days
AbbVie Just Raised Its Dividend by 5.5%. Should You Buy ABBV Stock Here? Barchart00:37 6-Nov-25
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know Zacks15:08 5-Nov-25
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk,… 24/7 Wall St.13:12 4-Nov-25
AbbVie Shines in Earnings Call Amid Growth and Challenges TipRanks00:26 4-Nov-25
Colorado Judge Denies AbbVie's Bid To Block State Drug Law Law36023:50 3-Nov-25
The AbbVie Decision and the Economics of Corporate Control Markets National Law Review20:45 3-Nov-25
AbbVie, Novartis Win Block of Oklahoma Drug Discount Law Bloomberg Law20:35 3-Nov-25
Do Wall Street Analysts Like AbbVie Stock? Barchart19:49 3-Nov-25
AbbVie (ABBV) Reports $14.5 Billion One-Off Loss, Undercutting Bullish Margin Recovery Narratives Simply Wall St15:58 1-Nov-25
Why AbbVie Stock Flopped on Friday The Motley Fool10:29 1-Nov-25
In the last month
Five Things To Know About AbbVie’s Q3 Sales And Earnings Report Scrip Pharma Intelligence21:26 31-Oct-25
AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised Zacks19:55 31-Oct-25
AbbVie Stock (ABBV) Wobbles as Humira Sales Take a Hit, Dims Q3 Glow TipRanks19:41 31-Oct-25
AbbVie raises full-year forecast, Newell Brands stock plunges Yahoo! UK & Ireland18:22 31-Oct-25
Why AbbVie (ABBV) Shares Are Falling Today Barchart18:11 31-Oct-25
AbbVie (ABBV) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates Zacks16:31 31-Oct-25
AbbVie boosts revenue forecast by $400M thanks to booming sales of Skyrizi, Rinvoq FiercePharma16:22 31-Oct-25
AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend Benzinga16:03 31-Oct-25
AbbVie raises outlook on strong sales of mainstay drugs Crain's Chicago Business15:25 31-Oct-25
Reddit, AbbVie, Western Digital: Earnings in focus Yahoo! US15:18 31-Oct-25
AbbVie (ABBV) Q3 Earnings and Revenues Surpass Estimates Zacks14:07 31-Oct-25
AbbVie Raises 2025 Adj. EPS Guidance Range RTT News12:46 31-Oct-25
AbbVie’s (NYSE:ABBV) Q3 Sales Beat Estimates Barchart12:34 31-Oct-25
AbbVie Reports Third-Quarter 2025 Financial Results PR Newswire (Press Release)11:52 31-Oct-25
Former AbbVie CFO’s Wilmette home commands well over list price in $6M sale The Real Deal17:41 30-Oct-25
AbbVie’s New Phase 1 Study: A Potential Game Changer? TipRanks16:33 30-Oct-25
AbbVie’s ABBV-1088 Study Termination: Implications for Investors TipRanks16:33 30-Oct-25
AbbVie's Earnings Outlook Benzinga14:22 30-Oct-25
AbbVie posts another win for Rinvoq in Phase III vitiligo trials Clinical Trials Arena14:04 30-Oct-25
Assessing AbbVie’s Valuation After 25% Gain and Immunology Drug Rollout in 2025 Simply Wall St04:35 30-Oct-25
AbbVie’s HIV Treatment Study Update: Key Insights for Investors TipRanks16:35 29-Oct-25
AbbVie's Autoimmune Drug Rinvoq Achieves Endpoints In Two Replicate Phase 3 Vitiligo Studies RTT News13:30 29-Oct-25
AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib… PR Newswire (Press Release)12:14 29-Oct-25
Chong Kun Dang wins EMA’s nod for Skyrizi biosimilar trial in Europe Korea Biomedical Review06:26 29-Oct-25
Should You Buy AbbVie Stock Ahead of Q3 Earnings Report? Zacks13:58 28-Oct-25
Allergan Aesthetics and Girls Inc., in Partnership with SkinSpirit, Inspire Future Women… PR Newswire (Press Release)13:01 28-Oct-25
AbbVie’s Latest Study on JUVÉDERM: What Investors Need to Know TipRanks23:40 27-Oct-25
AbbVie’s Mass Balance Study of ABBV-1354: Key Insights for Investors TipRanks23:10 27-Oct-25
AbbVie Advances with Emraclidine Study in Elderly: A Potential Game Changer? TipRanks23:10 27-Oct-25
AbbVie Defends Challenge Of Colorado's Discount Drug Law Law36022:30 27-Oct-25
AbbVie’s New Study on ELAPR002f Gel: A Potential Game-Changer for Acne Scars TipRanks22:08 27-Oct-25
AbbVie’s New Phase 2 Study Targets MET Amplification in Solid Tumors TipRanks21:17 27-Oct-25
AbbVie’s Promising Study on ABBV-6628 for Geographic Atrophy: What Investors Need to Know TipRanks20:36 27-Oct-25
AbbVie’s Cariprazine Study: A New Chapter in Pediatric Treatment TipRanks16:42 27-Oct-25
AbbVie’s ABBV-303 Study Terminated: Implications for Investors TipRanks16:42 27-Oct-25
AbbVie’s Fosigotifator Study Termination: Impact on MDD Treatment Pipeline TipRanks16:42 27-Oct-25
AbbVie Withdraws Study on Hair Loss in Oriahnn Users: Market Implications TipRanks16:42 27-Oct-25
AbbVie’s AML Study Termination: Implications for Investors TipRanks16:42 27-Oct-25
AbbVie’s Elagolix Pregnancy Study Terminated: Market Implications TipRanks16:32 27-Oct-25
Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade Yahoo! US15:50 26-Oct-25
AbbVie’s ABBV-932 Study: A New Hope for Bipolar Disorder Treatment? TipRanks17:36 24-Oct-25
AbbVie’s Upadacitinib Study Completes: Promising Results for Atopic Dermatitis TipRanks17:36 24-Oct-25
Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for Zacks16:03 24-Oct-25
Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It? Zacks15:32 24-Oct-25
Parkinson’s Untangled: Advocating for a clearer care pathway PoliticsHome14:17 24-Oct-25
AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth The Motley Fool18:20 23-Oct-25
AbbVie: Navigating Challenges and Seizing Opportunities in the Pharma Sector The Motley Fool00:20 23-Oct-25
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks23:49 22-Oct-25
YieldBoost AbbVie From 2.9% To 6.9% Using Options Nasdaq17:03 22-Oct-25
AbbVie Up More Than 30% in 6 Months: How to Play the Stock Zacks16:31 22-Oct-25
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks15:10 22-Oct-25
Qualcomm, Aptiv, Palo Alto And A Health Care Stock On CNBC's 'Final Trades' Benzinga13:24 22-Oct-25
AbbVie’s Atogepant Study: A Step Forward in Migraine Prevention TipRanks17:34 21-Oct-25
The Confidence Project by BOTOX® Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients AbbVie (Press Release)13:08 21-Oct-25
Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings Zacks16:19 20-Oct-25
AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study Reuters14:13 20-Oct-25
RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head… AbbVie (Press Release)13:02 20-Oct-25
Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts The Hindu Business Line11:27 19-Oct-25
Novo Nordisk Adds US PR Vet Miley O'Dwyer's PR Daily20:58 17-Oct-25
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin PR Newswire (Press Release)14:03 17-Oct-25
AbbVie’s Phase 2 Study on CLL/SLL Treatment: Key Updates and Market Impact TipRanks17:37 16-Oct-25
AbbVie’s Venetoclax Study Completion: A Potential Boost for Investors TipRanks17:37 16-Oct-25
New clinical data on solid tumour therapies Pharmaceutical Field13:48 16-Oct-25
AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks23:52 15-Oct-25
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to… Business Wire (Press Release)13:27 15-Oct-25
AbbVie hosts 2025 Pharma Leaders Conference Chemical & Engineering News21:02 14-Oct-25
Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie? Zacks17:19 14-Oct-25
Amazon, AbbVie, Datadog And A Financial Stock: CNBC's 'Final Trades' Benzinga13:21 14-Oct-25
FDA approves AbbVie’s Rinvoq for inflammatory bowel disease Pharmaceutical Technology11:29 14-Oct-25
AbbVie unveils new data on solid tumour therapies PharmaTimes09:55 14-Oct-25
U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the… AbbVie (Press Release)16:07 13-Oct-25
Hugel taps ex-AbbVie executive as new global CEO The Korea Herald13:45 13-Oct-25
AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies… PR Newswire (Press Release)12:18 13-Oct-25
Pharma companies announce direct-to-consumer sales and price cuts in US The Economic Times09:20 13-Oct-25
HMC, AbbVie sign MoU to bolster clinical research Gulf Times06:44 12-Oct-25
HMC cooperates with international company to strengthen clinical research The Peninsula13:22 11-Oct-25
AbbVie (ABBV): Assessing Valuation After Recent Gains and Investor Pause Simply Wall St20:11 10-Oct-25
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks15:04 10-Oct-25
What to Expect From AbbVie's Q3 2025 Earnings Report Barchart08:02 10-Oct-25
Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing The Motley Fool17:20 9-Oct-25
AbbVie vs. Eli Lilly: Which Large Drugmaker Has the Edge in 2025? Zacks16:19 9-Oct-25
REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting PR Newswire (Press Release)12:08 9-Oct-25
How pharma giant AbbVie holds leaders accountable for culture Fortune07:21 9-Oct-25

      
            
      
    view more headlines
   
      
      
      
7 Nov 18:45
   
AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
AbbVie

Latest News

AbbVie News

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories
